
Oil prices are back in focus after renewed attacks on tankers in the Strait of Hormuz, and that puts a spotlight on income you can actually see hitting your account. When markets are jumpy and energy costs are less predictable, Australian dividend stocks with yields above 3% and a track record of well covered, growing payouts can feel like solid ground. This article walks through three such dividend heavyweights from the screener and explains what sets each one apart.
The three stocks highlighted here offer a compelling starting point if you want exposure to higher yielding dividends that look well covered, growing and relatively steady. However, if you want the strongest names, these 4 dividend aristocrats stocks are the top of the list.
Overview: Medibank Private is an Australian insurer that provides private health cover and related health services, mainly through recurring premium income.
Operations: Medibank Private generates about A$8.6b from Health Insurance and A$635 million from Medibank Health, almost entirely within Australia.
Market Cap: A$13.2b
Medibank Private matters for this Dividend Powerhouses screener because its health insurance premiums behave like subscription income. This is the kind of recurring cash flow that can help support a 3%+ dividend yield through different parts of the cycle.
"The expansion and scaling of primary care clinics, virtual health, and home care offerings position Medibank to benefit from the shift in consumer preferences toward preventative care and at-home healthcare, helping to differentiate its offering, limit claims inflation, and improve net margins."
The real swing factor for Medibank Private’s dividend appeal is what happens if one unseen regulatory or funding pressure tightens unexpectedly.
If that kind of pressure is what you are weighing up, the full narrative for Medibank Private explains how Medibank Private could still keep its dividend engine accelerating.
Overview: ARB Corporation designs and sells 4x4 and off-road vehicle accessories and camping gear that underpin its dividend-paying cash flows.
Operations: ARB generates about A$706.6 million from motor vehicle accessories and light metal engineering, primarily across Australasia, Thailand, the USA and other regions.
Market Cap: A$1.4b
ARB matters for a Dividend Powerhouses screen because its aftermarket 4x4 accessories and camping products create repeat demand that can help underpin a 3%+ yield.
"While numerous smaller competitors exist and keep the company on its toes, ARB has expressed a willingness to acquire specialised operators that align with its quality focus."
What happens to ARB’s dividend appeal will hinge on how one unseen pressure shapes the balance between product investment and cash returns.
That pressure point is exactly what the full narrative for ARB unpacks, showing how ARB could keep cash returns accelerating even as it keeps investing in its off-road ecosystem.
Overview: nib holdings is a private health insurer that covers Australian residents and international members. Its local health insurance arm provides the main dividend-supporting cash flow.
Operations: nib holdings generates about A$3b from Australian Residents Health Insurance, A$432 million from New Zealand Insurance and A$245 million from International Health Insurance, with smaller contributions from travel, Thrive and health services.
Market Cap: A$3.2b
nib holdings matters for this Dividend Powerhouses screen because its Australian residents health insurance book throws off recurring premiums that help fund a 3%+ yield, while newer services broaden where those cash flows come from.
"Expansion of health management and preventative care offerings (telehealth, wellbeing programs, in-home care, no/known gap networks) is broadening revenue streams, improving customer retention, and actively managing claims inflation, positively impacting both top-line growth and future claims ratios."
What happens to nib holdings’ appeal as a steady dividend payer now depends on how one unresolved pressure shapes future profitability.
That pressure is exactly what the full narrative for nib holdings unpacks, describing how nib holdings could focus on preventative care and overseas segments as part of its broader dividend narrative.
Fresh dividend and growth stories can start to break out quietly. Momentum builds, prices start flying and latecomers get caught chasing. Scan under the radar for now and act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com